About
NeoNavia AB is a privately held, founder-led Swedish MedTech company focused on advancing breast cancer diagnostics. Its first product, the NeoNavia Biopsy System, is an innovative breast biopsy solution that combines advanced needle insertion technology with superior sampling efficiency, ensuring precision and diagnostic reliability. With regulatory approvals in the EU and the US, NeoNavia is driving innovation and shaping the future of minimally invasive breast biopsy procedures. NeoNavia GmbH is a fully operational, wholly owned subsidiary of NeoNavia AB, responsible for sales activities and reimbursement solutions in the DACH region.
Technologies
Outlook
Microsoft Office 365
Amazon AWS
LeadForensics
Google Tag Manager
reCAPTCHA
Mobile Friendly
Keywords
medical equipment manufacturing
medical diagnostics
axillary lymph node biopsy
medical devices
high velocity needle insertion
needle insertion technology
pulse technology
healthcare equipment & supplies
regulatory approvals
core needle biopsy
pneumatic needle insertion
medical equipment and supplies manufacturing
adaptive open-tip needle
clinical research
medical device innovation
patented pulse technology
ultrasound-guided biopsy
safety and precision
biopsy system
patent protection
tissue sampling
controlled tissue sampling
vacuum-assisted biopsy
medical device
dense breast tissue biopsy
innovative biopsy technology
diagnostic reliability
breast cancer diagnostics
minimally invasive procedure
clinical evaluation
Company Information
-
Employees 4
